1-benzylimidazole

Names

[ Name ]:
1-benzylimidazole

[Synonym ]:
1-BENZYL IMIDAZOLE
MFCD00005296
Imidazole,1-benzyl
1H-Imidazole, 1-(phenylmethyl)-
1-benzylimidazole
1H-Imidazole, 1- (phenylmethyl)-
BENZYLIMIDAZOLE
1-Benzyl-1H-imidazole
N-benzylimidazole
EINECS 224-200-4
3-Benzylimidazole

Biological Activity

[Description]:

1-Benzyl-1H-imidazole is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

[Related Catalog]:

Research Areas >> Others

[In Vitro]

Benzylimidazole 是一种选择性血栓素合成酶抑制剂和 UDP-葡萄糖醛基转移酶刺激剂。血栓素合成酶是一种细胞色素 P450 酶。细胞色素 P450 蛋白参与催化药物代谢和胆固醇、类固醇和其他脂类合成的许多反应。该酶在一些病理生理过程中起重要作用，包括止血、心血管疾病和中风。该基因表达两种转录变体。1-苯并咪唑选择性抑制血栓博烷合成酶活性。1-苯并咪唑降低大鼠脑缺血再灌注损伤后 TXB2 水平，增加血流量。雄性 Wistar 大鼠经胃给予 1-苯并咪唑 (25、75和100 mg/kg/天) 可引起剂量依赖性肝炎。1-苯并咪唑降低血浆甘油三酯水平 60-70%。1-苯并咪唑刺激三种不同形式的 UDP-葡萄糖醛基转移酶。1-苯并咪唑对 4-甲基菊酮、1-萘酚、吗啡和一种单萜类醇 nopol 的活性显著提高。苯并咪唑呈浓度依赖性增加肝细胞 CYP1A 催化活性和 CYP1A mRNA。

[References]

[1]. Pettigrew LC, Grotta JC, Rhoades HM, et al. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain[J]. Stroke, 1989, 20(5): 627-632

[2]. Magdalou J, Totis M, Boiteux-Antoine AF, et al. Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxy hydrolases and UDP-glucuronosyltransferases in rat liver[J]. Biochemical pharmacology, 1988, 37(17): 3297-330 Shen RF, Tai H H. Thromboxanes: synthase and receptors[J]. Journal of biomedical science , 1998, 5(3): 153-17

[3]. Shen RF, Tai H H. Thromboxanes: synthase and receptors[J]. Journal of biomedical science, 1998, 5(3): 153-17

[4]. Navas JM, Chana A, Herradón B, et al. Induction of CYP1A by the N‐imidazole derivative, 1‐benzylimidazole[J]. Environmental toxicity and chemistry, 2003, 22(4): 830-83

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
310.0±11.0 °C at 760 mmHg

[ Melting Point ]:
68-70 °C(lit.)

[ Molecular Formula ]:
C₁₀H₁₀N₂

[ Molecular Weight ]:
158.20

[ Flash Point ]:
141.3±19.3 °C

[ Exact Mass ]:
158.084396

[ PSA ]:
17.82000

[ LogP ]:
1.46

[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C

[ Index of Refraction ]:
1.580

[ Water Solubility ]:
insoluble

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2933290090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Customs

[ HS Code ]: 2933290090

[ Summary ]:
2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins

Bioorg. Med. Chem. 17 , 896-904, (2009)

This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret...

Toward prediction of alkane/water partition coefficients.

J. Med. Chem. 51 , 3720-30, (2008)

Partition coefficients were measured for 47 compounds in the hexadecane/water ( P hxd) and 1-octanol/water ( P oct) systems. Some types of hydrogen bond acceptor presented by these compounds to the pa...

QSAR-based solubility model for drug-like compounds.

Bioorg. Med. Chem. 18 , 7078-84, (2010)

Solubility plays a very important role in the selection of compounds for drug screening. In this context, a QSAR model was developed for predicting water solubility of drug-like compounds. First, a se...